Canadian Institutes of Health Research

Look at the Science

Female grant applicants do about as well as their male colleagues when the review focuses on the science proposed, according to Nature News.

Canadian Rare Diseases Models and Mechanisms network receives C$2.3 million to support model organism research

NEW YORK (GenomeWeb) – Four Canadian government research funding agencies will spend around C$7.3 million (US$6.7 million) to create a cloud computing facility and data mining tools that will enable researchers to access and use data from the International Cancer Genome Consortium.

NEW YORK (GenomeWeb News) – The Canadian Institutes of Health Research and Genome Canada plan to provide C$2.3 million (US$2.2 million) to fund a national network to help clinical researchers studying genes involved in rare diseases to partner with experts in model organisms, CIHR said yesterday.

NEW YORK (GenomeWeb News) – Canada's government has awarded C$10 million (US$9.7 million) to fund a research program at McGill University focused on pain genetics that will be headed by Luda Diatchenko, McGill said yesterday.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institutes of Health Research said today that a number of new genomics and personalized medicine research projects focused on tackling common, complex, and rare diseases have received C$150 million (US$147.5 million) in new grants.

NEW YORK (GenomeWeb News) – The Canadian government has invested C$19 million (US$19.3 million) in new collaborative research projects to develop a range of biomedical technologies including tools to advance microfluidics, mass spectrometry, and drug screening.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institute of Health Research will award C$6.3 million (US$6.1 million) to research projects under its 2012 Bioinformatics and Computational Biology Competition to develop new tools to deal with the large volumes of data being generated fr

The device, named the Verisante Aura, uses Raman spectroscopy to measure levels of various biomarkers – including proteins, nucleic acids, and metabolites – in skin lesions. In initial clinical trials it distinguished between benign and malignant lesions with 100-percent sensitivity and 70-percent specificity.

Pages

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.